News
Febuxostat does not appear to increase the risk for major adverse cardiovascular events when compared with no urate-lowering ...
XORTX will focus on key steps to advance a NDA filing for Gout indication ● CALGARY, Alberta, April (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “C ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback